SAN FRANCISCO - At the 56(th) Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 14-16 in San Francisco, Elekta (booth #1308) will highlight solutions that support the connections health care providers make to their practices, their patients and the world.
Elekta's theme at ASTRO 2014 is: Connected Care. Because the future is collaborative. As software continues to play a critical role in cancer care, Elekta will highlight Information-guided cancer care™, an Elekta concept that will transform cancer care by enabling clinicians to connect with the information they need to treat patients more effectively.
A key cornerstone of Information-guided cancer care is Elekta's Knowledge Management platform, an oncology analytics solution that provides real-time dashboards and reports to help improve the quality of cancer care. As the operator of the largest aggregated oncology repository in the market, with more than two million patients, Elekta will showcase its Healthcare Analytics* dashboards and robust visualization tools at ASTRO.
"Aside from oncology data, our analytics solutions will help our users to collect, aggregate and analyze big data that patients are generating throughout the experience, regardless of the source. This data will help patients and physicians in the treatment decision making process," says Todd Powell, Executive Vice President, Elekta Software. "Today, about two-thirds of patients are treated without using evidence-based protocols. With our Healthcare Analytics solutions, providers will be able to measure, monitor and establish comprehensive cancer care best practices, while adhering to regulatory guidelines."
"As we move forward together, our goal is to help you efficiently deliver the best possible cancer care: connected care," says Jay Hoey, Executive Vice President, Elekta North America. "We are committed to comprehensive care that reaches across disciplines, care that keeps patients at the center. We design technologies that help you manage your practice and treat your patients efficiently, and we create knowledge systems that help you connect with other clinicians as you work to improve outcomes."
At ASTRO 2014, Elekta will also showcase:
-- Versa HD™ linear accelerator: In a single system, Versa HD - with
sophisticated beam-shaping technology and High Dose Rate mode delivery -
can deliver conventional therapies for indications commonly seen in the
clinic, while also permitting treatment of complex cancers that require
extreme targeting accuracy.
-- Leksell Gamma Knife®: The next generation of intracranial stereotactic
radiosurgery, Leksell Gamma Knife continues to evolve, expanding its
range of techniques and radiosurgical speed and effectiveness.
-- Esteya® electronic brachytherapy: A patient-friendly electronic
brachytherapy solution for treating skin cancer, Esteya features a
portable set-up that enables the system to be used in any minimally
shielded treatment room. With a fully optimized workflow, Esteya
requires only a couple of minutes from patient entry to start of
-- Monaco® treatment planning: A comprehensive treatment planning solution
for 3D, IMRT, VMAT and stereotactic techniques.
-- MOSAIQ® oncology information system: The latest version of MOSAIQ with
stereotactic localization, plan review and approval, as well as enhanced
Additional Elekta activities
The 23(rd) Annual Elekta Oncology Users Meeting (EOUM) convenes Saturday, September 13 at the Moscone Center. Customers using any Elekta solution are welcome to attend and take advantage of this free educational opportunity. Chief Quality Officer and Executive Vice President of the Barbara Ann Karmanos Cancer Institute, Justin Klamerus, MD, will be the keynote speaker. To learn more about the EOUM, visit www.elekta.com/EOUM2014.
The Elekta Charity Bash, benefiting San Francisco-based Women's Cancer Research Center (WCRC), will be held September 13 from 7:30-11:30 p.m. at the San Francisco Design Center Galleria. Elekta is proud to support the WCRC, which provides an array of services designed to help clients cope with the physical and emotional changes caused by treatment, the disease, and the challenges of caring for someone with cancer. Tickets must be purchased in advance for this event and will not be sold at the door. One hundred percent of the event's ticket proceeds will benefit the WCRC.
Elekta's Capital Markets Day will be held Monday, September 15, from 9-11:30 a.m. at the San Francisco Marriott Marquis Hotel. Elekta's President and CEO, Niklas Savander, together with other members of Elekta's management team, will present the company and highlight the product and solutions portfolio. Visit elekta.com to watch live.
Follow the Elekta Twitter handle, @Elekta, for updates from the ASTRO show floor. To learn more about Elekta at ASTRO, visit www.elekta.com/connectedcare.
*Elekta Healthcare Analytics is a works-in-progress and not currently available for sale.
For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: email@example.com
Time zone: CET: Central European Time
Raven Canzeri, Global Public Relations Manager, Elekta
Tel: +1 770-670-2524, e-mail: firstname.lastname@example.org
Time zone: ET: Eastern Time
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker STO:EKTAB. Website: www.elekta.com.